Cancer immunotherapy has the potential to revolutionize the treatment of malignant tumors,
but its effectiveness is limited by the low immune response rate and immune‐related …

Pyroptosis, an emerging mechanism of programmed cell death, holds great potential to
trigger a robust antitumor immune response. Platinum‐based chemotherapeutic agents can …

Cancer immunotherapy has gained popularity in recent years in the search for effective
treatment modalities for various malignancies, particularly those that are resistant to …

Inducing pyroptosis in cancer cells can result in a strong anti-tumor immune response. Our
preliminary study indicates that pyroptosis can be temporarily strengthened by disrupting …

Cancer remains a significant global health concern, necessitating the development of
innovative therapeutic strategies. This research paper aims to investigate the role of …

Cancer stem cells (CSCs) drive tumor initiation, progression, and therapeutic resistance due
to their self-renewal and differentiation capabilities. Despite encouraging progress in cancer …

Effective antitumor immunotherapy depends on evoking a cascade of cancer-immune cycles
with lymph nodes (LNs) as the initial sites for activating antitumor immunity, making drug …

Significant advancements have been made in the application of chimeric antigen receptor
(CAR)-T treatment for blood cancers during the previous ten years. However, its …

Nanoplastics are a common type of contaminant in the air. However, no investigations have
focused on the toxic mechanism of lung injury induced by nanoplastic exposure. In the …

Precise image-guided cancer immunotherapy holds immense potential in revolutionizing
cancer treatment. The strategies facilitating activatable imaging and controlled therapeutics …